Cargando…

Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator

BACKGROUND: Our objective was to assess the accuracy of transabdominal ultrasound (TAUS) measured prostate volume in the primary care setting with transrectal ultrasound (TRUS) measured prostate volume by the urologist as the reference test. Furthermore, our objective was to assess whether risk-stra...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vos, Ivo I., Drost, Frank-Jan H., Bokhorst, Leonard P., Alberts, Arnout R., van Gelder, Martine, Herman, Erik M., Boswinkel, Wouter D., Bangma, Chris H., Roobol, Monique J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006014/ https://www.ncbi.nlm.nih.gov/pubmed/36915892 http://dx.doi.org/10.21037/tau-22-640

Ejemplares similares

Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment
por: de Bekker-Grob, E W, et al.
Publicado: (2013)

Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App
por: Pereira-Azevedo, Nuno, et al.
Publicado: (2017)

Prostate cancer screening in Europe and Asia
por: Zhang, Kai, et al.
Publicado: (2017)

Application of Bland-Altman Method in Comparing Transrectal and Transabdominal Ultrasonography for Estimating Prostate Volume
por: Babaei Jandaghi, Ali, et al.
Publicado: (2015)

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Ethnicity and prostate cancer: the way to solve the screening problem?
por: Bokhorst, Leonard P., et al.
Publicado: (2015)

Risk Factors for Acute Prostatitis after Transrectal Biopsy of the Prostate
por: Kim, Sang Jin, et al.
Publicado: (2010)

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam
por: Wever, Elisabeth M., et al.
Publicado: (2010)

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer
por: Venderbos, Lionne D. F., et al.
Publicado: (2017)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

Correlations between the Various Methods of Estimating Prostate Volume: Transabdominal, Transrectal, and Three-Dimensional US
por: Kim, Sun Ho, et al.
Publicado: (2008)

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome
por: Pereira-Azevedo, Nuno, et al.
Publicado: (2018)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
por: Gupta, A, et al.
Publicado: (2010)

Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam
por: Hogenhout, Renée, et al.
Publicado: (2022)

Analyzing the learning curves of a novice and an experienced urologist for transrectal magnetic resonance imaging-ultrasound fusion prostate biopsy
por: Cata, Emanuel Darius, et al.
Publicado: (2021)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Prostate MRI – an update for the referring urologist
por: Czarniecki, Marcin, et al.
Publicado: (2016)

Can expressed prostatic secretions affect prostate biopsy decision of urologist?
por: Ergün, Osman, et al.
Publicado: (2019)

Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan
por: Nakayama, Masahiko, et al.
Publicado: (2018)

Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists
por: Dovey, Zachary, et al.
Publicado: (2020)

Microbiological Characteristics of Acute Prostatitis After Transrectal Prostate Biopsy
por: Bang, Jun-Ho, et al.
Publicado: (2013)

New Bacterial Infection in the Prostate after Transrectal Prostate Biopsy
por: Seo, Yumi, et al.
Publicado: (2018)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic
por: Osses, Daniël F., et al.
Publicado: (2018)

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease
por: Schoots, Ivo G., et al.
Publicado: (2018)

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis
por: Hollemans, Eva, et al.
Publicado: (2018)

External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort
por: Chandra Engel, Jan, et al.
Publicado: (2022)

Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial
por: Carbunaru, Samuel, et al.
Publicado: (2023)

Early detection of prostate cancer using prostate-specific antigen testing: an empirical evaluation among general practitioners and urologists
por: Kappen, Sanny, et al.
Publicado: (2019)

Classification of Focal Prostatic Lesions on Transrectal Ultrasound (TRUS) and the Accuracy of TRUS to Diagnose Prostate Cancer
por: Lee, Ho Yun, et al.
Publicado: (2009)

Can transrectal prostate ultrasound compete with multiparametric MRI in the detection of clinically significant prostate cancer?
por: Grey, Alistair D. R., et al.
Publicado: (2020)

Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis?
por: Moe, Andrew, et al.
Publicado: (2020)

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
por: Venderbos, Lionne D. F., et al.
Publicado: (2015)

Geographic Analysis of Urologist Density and Prostate Cancer Mortality in the United States
por: Yao, Nengliang, et al.
Publicado: (2015)

Variability in accuracy of prostate cancer segmentation among radiologists, urologists, and scientists
por: Chen, Michael Y., et al.
Publicado: (2020)

Analysis of Preoperative Detection for Apex Prostate Cancer by Transrectal Biopsy
por: Sazuka, Tomokazu, et al.
Publicado: (2013)

Correlation of transrectal ultrasonographic findings with histo pathology in prostatic cancer
por: Ganie, Farooq Ahmad, et al.
Publicado: (2014)

The role of transrectal ultrasound in the diagnosis of prostate cancer: new contributions
por: Lopes, Pedro Marinho, et al.
Publicado: (2015)

Transrectal Ultrasound and Photoacoustic Imaging Probe for Diagnosis of Prostate Cancer
por: Jang, Jihun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ojl6qbenbt51q79ktlottf68ml